[en] We report our experience over the last seventeen
years (1985-2002) of the treatment of acute lymphoblastic leukemia
(ALL) in children at the University of Liege Pediatric
Department of Hematogy-Oncology (CHU-Sart Tilman and
CHR-Citadelle). Seventy seven children are enrolled in our
study; the mean follow-up is 6,7 years.
The 5 years over all survival and the disease free survival for the
entire group are respectively 83 % and 79 %. Prognostic factors
shown in our study are sex, high white blood cells counts at diagnosis
and immunophenotypes
Disciplines :
Oncology Pediatrics
Author, co-author :
Panizzotto, S
DRESSE, Marie-Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Service de pédiatrie (CHR)
Schmitz, V
FORGET, Patricia ; Centre Hospitalier Universitaire de Liège - CHU > Service de pédiatrie (CHR)
Kurz, Xavier
Hoyoux, Claire ; Université de Liège > Département des sciences cliniques > Département des sciences cliniques
Language :
English
Title :
Acute lymphoblastic leukemia in children
Publication date :
2005
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
